The Department of Pediatric Hematology and Oncology, Center for Pediatrics (medical director: Prof. T. Feuchtinger) has an opening in the field of novel cell, immune and gene therapies starting 01.08.2025 for a
PhD candidate (Biology, Biochemistry, Molecular Medicine or related) (m/f/d)
This PhD project aims to develop innovative CAR T cell immunotherapies for patients with T-cell acute lymphoblastic leukemia. The research will utilize novel binders for T-ALL antigens generated through collaborative efforts. The candidate will conduct comprehensive in vitro and in vivo functional testing to evaluate efficacy and safety of new immunotherapies. The ultimate goal of this project is to translate these findings into a clinical CAR T cell trial for T-ALL patients.
We offer:
- exceptional environment for translational immunology & oncology research
- motivated team of lymphocyte engineers
- modern laboratory with excellent infrastructure
- widespread local, national and international collaborations
You qualifications:
- Master degree in biology, biochemistry, molecular medicine or related fields
- strong background in cell biology, immunology and molecular biology
- Experience in and readiness to perform in vivo functional tests in mouse models
- good command of spoken and written English
Employment will be on limited term with possible extension.
We look forward to your application (CV, letter of motivation, references with contact information). Please submit your application via our online portal until May 30, 2025.
University Medical Center Freiburg Center for Pediatrics
Department of Pediatric Hematology and Oncology
Dr. med. Semjon Willier
Breisacher Str. 62, D-79106 Freiburg
For further information, please reach out at any time.
semjon.willier@uniklinik-freiburg.de
